Prevalence and characteristics of HPV-driven oropharyngeal cancer in France
Tóm tắt
Từ khóa
Tài liệu tham khảo
Shield, 2017, The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012, CA Cancer J Clin., 67, 51, 10.3322/caac.21384
St Guily, 2011, Human papillomavirus genotype distribution in oropharynx and oral cavity cancer in France–The EDiTH VI study, J Clin Virol, 51, 100, 10.1016/j.jcv.2011.03.003
Gavid, 2013, Human Papillomavirus and head and neck squamous cell carcinomas in the South-East of France: prevalence, viral expression, and prognostic implications, Acta Otolaryngol, 133, 538, 10.3109/00016489.2012.747221
Lacau St Guily, 2017, Oropharyngeal cancer prognosis by tumour HPV status in France: The multicentric Papillophar study, Oral Oncol, 67, 29, 10.1016/j.oraloncology.2017.01.012
Haeggblom, 2017, Time to change perspectives on HPV in oropharyngeal cancer. A systematic review of HPV prevalence per oropharyngeal sub-site the last 3 years, Papillomavirus Res, 4, 1, 10.1016/j.pvr.2017.05.002
Schache, 2016, HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease Etiology, Cancer Res., 76, 6598, 10.1158/0008-5472.CAN-16-0633
Mirghani, 2014, Human papilloma virus testing in oropharyngeal squamous cell carcinoma: what the clinician should know, Oral Oncol., 50, 1, 10.1016/j.oraloncology.2013.10.008
Garnaes, 2015, A high and increasing HPV prevalence in tonsillar cancers in Eastern Denmark, 2000-2010: the largest registry-based study to date, Int J Cancer., 136, 2196, 10.1002/ijc.29254
Näsman, 2009, Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?, Int J Cancer., 125, 362, 10.1002/ijc.24339
Rietbergen, 2013, Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm, Int J Cancer., 132, 1565, 10.1002/ijc.27821
Van Limbergen, 2014, HPV-related oropharyngeal cancers in Flanders(Belgium): a multicenter study, B-ENT., 10, 7
Tinhofer, 2015, Contribution of human papillomavirus to the incidence of squamous cell carcinoma of the head and neck in a European population with high smoking prevalence, Eur J Cancer, 51, 514, 10.1016/j.ejca.2014.12.018
Strojan, 2015, Incidence trends in head and neck squamous cell carcinoma in Slovenia, 1983-2009: role of human papillomavirus infection, Eur Arch Otorhinolaryngol., 272, 3805, 10.1007/s00405-014-3459-7
Broglie, 2017, Impact of human papillomavirus on outcome in patients with oropharyngeal cancer treated with primary surgery, Head Neck., 39, 2004, 10.1002/hed.24865
Rodrigo, 2014, Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain (1990-2009), Int J Cancer., 134, 487, 10.1002/ijc.28355
Polz-Gruszka, 2015, Prevalence of Human papillomavirus (HPV) and Epstein-Barr virus (EBV) in oral and oropharyngeal squamous cell carcinoma in south-eastern Poland, Infect Agent Cancer., 10, 37, 10.1186/s13027-015-0031-z
Baboci, 2016, Low prevalence of HPV-driven head and neck squamous cell carcinoma in North-East Italy, Papillomavirus Res., 2, 133, 10.1016/j.pvr.2016.07.002
Romanitan, 2008, Human papillomavirus frequency in oral and oropharyngeal cancer in Greece, Anticancer Res., 28, 2077
Ursu, 2018, Role of mucosal high-risk human papillomavirus types in head and neck cancers in Romania, PLoS One., 13, e0199663, 10.1371/journal.pone.0199663
Chaturvedi, 2011, Human Papillomavirus and rising oropharyngeal incidence in the United States, J Clin Oncol., 10, 4294, 10.1200/JCO.2011.36.4596
D’Souza, 2007, Case control study of human Papillomavirus and oropharyngeal cancer, New Engl J Med., 356, 1944, 10.1056/NEJMoa065497
O’Sullivan, 2016, Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study, Lancet Oncol., 17, 440, 10.1016/S1470-2045(15)00560-4